halofenate has been researched along with clofibrate in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 32 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cenedella, RJ | 1 |
| Ryan, JR | 1 |
| Witte, EC | 1 |
| Jain, AK; McMahon, FG; Ryan, JR | 1 |
| Azarnoff, DL; Dujovne, CA; Huffman, DH; Hurwitz, A; Pentikäinen, P; Shoeman, DW | 1 |
| Colman, RW | 3 |
| Friedberg, SJ; Kudzma, DJ | 1 |
| Joffe, BI; Krut, LH; Seftel, HC | 1 |
| Mustard, JF; Packham, MA | 1 |
| Dorph, DJ; Smith, H; Yü, TF | 1 |
| Caen, JP; Wautier, JL | 1 |
| Ardlie, NG | 1 |
| Hamilton, RD; Hearn, T; Kanner, IF; Rees, ED; Wasson, S | 1 |
| Bennett, JS; Colman, RW; Cooper, RA; Shattil, SJ; Sheridan, JF | 1 |
| Hucker, HB; Jordan, PT; Kling, P; MacMillan, A; Minsker, DH | 1 |
| Kritchevsky, D | 1 |
| Germershausen, JI; Greenspan, MD; Mackow, R | 1 |
| Edwards, KD; Schapel, GJ | 1 |
| Bowley, M; Brindley, DN | 1 |
| Rottiers, R; van Egmond, J | 1 |
| Gotto, AM; Yeshurun, D | 1 |
| Lin, CY; Smith, S | 1 |
| Cenedella, RJ; Crouthamel, WG | 1 |
| Madhosingh, C; Orr, W | 1 |
| de Neuman, MP; Martiarena, JL; Neuman, J; Pesce, R; Talmasky, S; Valero, E | 1 |
| Ashbrook, JD; Fletcher, JE; Santos, EC; Spector, AA | 1 |
| Germershausen, JI; Greenspan, MD | 1 |
| Fumagalli, R; Paoletti, R; Sirtori, C | 1 |
| Davignon, J; Gattereau, A; Lewis, W; Verdy, M | 1 |
| Beynen, AC; Geelen, MJ | 1 |
6 review(s) available for halofenate and clofibrate
| Article | Year |
|---|---|
Clinical pharmacology of platelets.
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation; Blood Platelets; Cell Membrane; Clofibrate; Cyproheptadine; Dipyridamole; Drug Therapy, Combination; Furosemide; Halofenate; Heparin; Humans; Hydrocortisone; Hydroxychloroquine; Methylprednisolone; Penicillin G; Platelet Aggregation; Propranolol; Prostaglandins; Sulfinpyrazone; Vitamin E | 1977 |
Hyperlipidemia in primary gout.
Topics: Adolescent; Adult; Aged; Aging; Alcohol Drinking; Cholesterol; Clofibrate; Dextrothyroxine; Diabetes Mellitus; Diet, Reducing; Gout; Halofenate; Humans; Hyperlipidemias; Male; Middle Aged; Obesity; Triglycerides | 1978 |
Pharmacology of platelet-suppressive agents.
Topics: Adenosine Diphosphate; Anti-Inflammatory Agents; Arachidonic Acids; Aspirin; Blood Platelets; Calcium; Cell Membrane; Clofibrate; Dipyridamole; Epoprostenol; Halofenate; Heparin; Humans; Imidazoles; Platelet Adhesiveness; Platelet Aggregation; Prostaglandins E; Prostaglandins, Synthetic | 1979 |
Newer hypolipidemic compounds.
Topics: Animals; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Clofibrate; Halofenate; Humans; Hypolipidemic Agents; Probucol; Rabbits; Rats; Structure-Activity Relationship; Triglycerides; Uric Acid | 1975 |
Hypolipidemic drugs.
Topics: Aminosalicylic Acids; Androgens; Bile Acids and Salts; Butyrates; Cellulose; Cholestyramine Resin; Clofibrate; Contraceptives, Oral; Female; Gonadal Steroid Hormones; Halofenate; Humans; Hyperlipidemias; Hypolipidemic Agents; Intestinal Absorption; Lignin; Lipid Metabolism; Lipid Mobilization; Male; Nafenopin; Neomycin; Nicotinic Acids; Oxandrolone; Probucol; Progestins; Sitosterols; Sterols; Thyroxine; Triglycerides | 1973 |
Short-term inhibition of fatty acid biosynthesis in isolated hepatocytes by mono-aromatic compounds.
Topics: Acetyl-CoA Carboxylase; Aminosalicylic Acid; Animals; Benzene Derivatives; Benzoates; Benzoic Acid; Carbohydrate Metabolism; Clofibrate; Coumaric Acids; Fatty Acids; Fenfluramine; Halofenate; Hydroxybenzoates; Lipids; Liver; Models, Biological; Oxidation-Reduction; Parabens; Rats; Salicylates; Salicylic Acid | 1982 |
8 trial(s) available for halofenate and clofibrate
| Article | Year |
|---|---|
The metabolic spectrum of halofenate.
Topics: Blood Glucose; Cholesterol; Clinical Trials as Topic; Clofibrate; Creatine Kinase; Glycolates; Halofenate; Humans; Hyperlipidemias; Probenecid; Protein Binding; Thyroid Function Tests; Thyroxine; Tolbutamide; Triglycerides; Uric Acid | 1975 |
Potentiation of hypoglycemic effect of sulfonylureas by halofenate.
Topics: Adult; Clinical Trials as Topic; Clofibrate; Diabetes Complications; Diabetes Mellitus; Drug Synergism; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Hypoglycemic Agents; Lipoproteins, VLDL; Male; Middle Aged; Phenformin; Sulfonylurea Compounds; Tolbutamide; Triglycerides | 1975 |
One-year trials with halofenate, clofibrate, and placebo.
Topics: Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Cholesterol; Clinical Trials as Topic; Clofibrate; Creatine Kinase; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Triglycerides; Uric Acid | 1976 |
Potentiation of hypoglycemic effect of chlorpropamide and phenfromin by halofenate.
Topics: Blood Glucose; Chlorpropamide; Clinical Trials as Topic; Clofibrate; Diabetes Mellitus; Drug Synergism; Glycolates; Halofenate; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Phenformin; Tolazamide; Tolbutamide | 1977 |
Comparison of clofibrate with halofenate in diabetics with hyperlipidaemia.
Topics: Aged; Cholesterol; Clinical Trials as Topic; Clofibrate; Diabetes Complications; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Male; Middle Aged; Triglycerides; Uric Acid | 1977 |
Halofenate in the treatment of type II hyperlipoproteinemia. Double blind comparison with clofibrate.
Topics: Adult; Blood Chemical Analysis; Body Weight; Cholesterol; Clinical Trials as Topic; Clofibrate; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Male; Middle Aged; Triglycerides | 1976 |
A one year double blind study of the effect of halofenate and clofibrate in patients with hyperlipoproteinemia.
Topics: Clofibrate; Drug Evaluation; Glycolates; Halofenate; Humans; Hyperlipidemias | 1975 |
A double-blind comparison of the hypolipidemic and hypouricemic action of halofenate and clofibrate in patients with hyperlipoproteinemia (types III, IV and V).
Topics: Cholesterol; Chylomicrons; Clinical Trials as Topic; Clofibrate; Glycolates; Halofenate; Humans; Hyperlipidemias; Lipoproteins, LDL; Lipoproteins, VLDL; Triglycerides; Uric Acid | 1973 |
18 other study(ies) available for halofenate and clofibrate
| Article | Year |
|---|---|
Hepatic triglyceride lipases--effect of clofibrate and halofenate.
Topics: Animals; Clofibrate; Fatty Acids, Nonesterified; Fatty Liver; Glycolates; Halofenate; Hydrogen-Ion Concentration; In Vitro Techniques; Lipase; Liver; Male; Orotic Acid; Rats; Triglycerides | 1976 |
Antihyperlipidaemic agents.
Topics: Animals; Cholesterol; Chylomicrons; Clofibrate; Dogs; Electrophoresis, Polyacrylamide Gel; Fatty Acids, Nonesterified; Halofenate; Humans; Hyperlipidemias; Hypolipidemic Agents; Ion Exchange Resins; Lipoproteins, LDL; Lipoproteins, VLDL; Nicotinic Acids; Species Specificity; Structure-Activity Relationship; Triglycerides; Ultracentrifugation | 1975 |
Platelet function in thrombosis and atherosclerosis.
Topics: Adenylyl Cyclases; Arteriosclerosis; Blood Platelets; Cell Membrane; Clofibrate; Cyclic AMP; Halofenate; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Thrombosis | 1978 |
Platelet function in hyperbetalipoproteinemia.
Topics: Adenosine Diphosphate; Adenylyl Cyclases; Blood Platelets; Clofibrate; Halofenate; Humans; Hyperlipidemias; Platelet Aggregation | 1978 |
Investigation of the role of arachidonic acid in platelet function and mechanisms for suppression of prostaglandin biosynthesis.
Topics: Arachidonic Acids; Aspirin; Blood Platelets; Clofibrate; Halofenate; Hypolipidemic Agents; Malondialdehyde; Prostaglandins; Serotonin | 1978 |
Halofenate: a potent inhibitor of normal and hypersensitive platelets.
Topics: Adenosine Diphosphate; Blood Platelets; Cholesterol; Clofibrate; Collagen; Depression, Chemical; Dose-Response Relationship, Drug; Epinephrine; Glycolates; Halofenate; Humans; Hypersensitivity; Platelet Aggregation; Serotonin | 1976 |
The effect of halofenate or halofenate free acid on human, rat and guinea pig platelet aggregation.
Topics: Animals; Clofibrate; Collagen; Female; Glycolates; Guinea Pigs; Halofenate; Humans; Male; Platelet Aggregation; Rats; Swine | 1976 |
Effect of halofenate and clofibrate on lipid synthesis in rat adipocytes.
Topics: Adipose Tissue; Animals; Citrates; Clofibrate; Fatty Acids; Glucose; Glycolates; Halofenate; In Vitro Techniques; Kynurenic Acid; Leucine; Oleic Acids; Palmitic Acids; Peptides; Pyruvates; Rats | 1975 |
Efficacy and interactions of oxandrolone, halo-fenate and clofibrate in a factorial study on experimental acute nephrotic hyperlipidemia.
Topics: Animals; Body Weight; Butyrates; Cholesterol; Clofibrate; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Female; Glycolates; Halofenate; Hyperlipidemias; Lipids; Liver; Nephrotic Syndrome; Organ Size; Oxandrolone; Puromycin Aminonucleoside; Rats; Statistics as Topic | 1975 |
Drugs affecting the synthesis of glycerides and phospholipids in rat liver. The effects of clofibrate, halofenate, fenfluramine, amphetamine, cinchocaine, chlorpromazine, demethylimipramine, mepyramine and some of their derivatives.
Topics: Amphetamine; Animals; Chlorpromazine; Clofenapate; Clofibrate; Dibucaine; Fenfluramine; Glycerides; Glycerol-3-Phosphate O-Acyltransferase; Halofenate; Imipramine; In Vitro Techniques; Kinetics; Liver; Pharmacology; Phospholipids; Pyrilamine; Rats | 1975 |
Drug treatment of hyperlipidemia.
Topics: Aminosalicylic Acids; Anabolic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Estrogens; Halofenate; Humans; Hyperlipidemias; Neomycin; Nicotinic Acids; Progesterone; Sitosterols | 1976 |
The effect of halofenate and clofibrate on aggregation and release of serotonin by human platelets.
Topics: Adenosine Diphosphate; Blood Platelets; Clofibrate; Collagen; Epinephrine; Glycolates; Halofenate; Humans; Platelet Aggregation; Serotonin | 1976 |
Halofenate and clofibrate: mechanism of hypotriglyceridemic action in the rat.
Topics: Animals; Clofibrate; Dietary Fats; Disease Models, Animal; Glycerol; Glycerophosphates; Glycolates; Halofenate; Intestine, Small; Kinetics; Lipid Metabolism, Inborn Errors; Liver; Male; Models, Biological; Rats; Triglycerides | 1976 |
Halofenate and clofibrate inhibition of pyruvate dehydrogenase from Fusarium culmorum.
Topics: Clofibrate; Fusarium; Glycolates; Halofenate; Pyruvate Dehydrogenase Complex | 1985 |
Influence of free fatty acid concentration on drug binding to plasma albumin.
Topics: Anilino Naphthalenesulfonates; Clofibrate; Fatty Acids, Nonesterified; Halofenate; Humans; Kinetics; Models, Biological; Oleic Acids; Palmitic Acids; Pharmaceutical Preparations; Potassium Iodide; Protein Binding; Serum Albumin; Spectrometry, Fluorescence | 1973 |
Effect of halofenate and clofibrate on growth and lipid synthesis in Saccharomyces cerevisiae.
Topics: Acetates; Carbon Dioxide; Carbon Isotopes; Chromatography, Gas; Clofibrate; Fatty Acids; Glucose; Glycolates; Halofenate; Hypolipidemic Agents; Lipids; Mass Spectrometry; Oleic Acids; Pyruvate Oxidase; Pyruvates; Saccharomyces cerevisiae; Sterols | 1973 |
Halofenate versus clofibrate in the management of true diabetes insipidus.
Topics: Adult; Clofibrate; Diabetes Insipidus; Diuresis; Female; Halofenate; Humans | 1974 |
The role of platelets in the genesis of ischemia.
Topics: Adenosine Diphosphate; Animals; Arteriosclerosis; Blood Platelets; Cholesterol; Clofibrate; Coronary Disease; Cyclic AMP; Death, Sudden; Diabetes Complications; Diabetes Mellitus; Halofenate; Humans; Hyperlipoproteinemia Type II; Platelet Aggregation; Prostaglandins; Smoking; Swine; Thrombin | 1982 |